Featured Publications
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma
Biswas D, Liu Y, Herrero J, Wu Y, Moore D, Karasaki T, Grigoriadis K, Lu W, Veeriah S, Naceur-Lombardelli C, Magno N, Ward S, Frankell A, Hill M, Colliver E, de Carné Trécesson S, East P, Malhi A, Snell D, O’Neill O, Leonce D, Mattsson J, Lindberg A, Micke P, Moldvay J, Megyesfalvi Z, Dome B, Fillinger J, Nicod J, Downward J, Szallasi Z, Hackshaw A, Jamal-Hanjani M, Kanu N, Birkbak N, Swanton C. Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma. Nature Cancer 2025, 6: 86-101. PMID: 39789179, PMCID: PMC11779643, DOI: 10.1038/s43018-024-00883-1.Peer-Reviewed Original ResearchConceptsLung adenocarcinomaStage I diseaseClinicopathological risk factorsSurvival of patientsResponse to treatmentRNA sequencing dataI diseaseSequence dataMetastatic clonesNeedle biopsyIndividual tumorsLung expressionTranscription signalsPrognostic informationWhole exomeExpressed genesChemotherapy sensitivityProspective validationSurvival associationsTranscriptomic heterogeneityHuman tumorsEvolutionary measuresChromosomal instabilityRisk factorsNatural history
2020
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
Houlihan C, Vora N, Byrne T, Lewer D, Kelly G, Heaney J, Gandhi S, Spyer M, Beale R, Cherepanov P, Moore D, Gilson R, Gamblin S, Kassiotis G, McCoy L, Swanton C, Consortium C, Hayward A, Nastouli E, Investigators S, Aitken J, Allen Z, Ambler R, Ambrose K, Ashton E, Avola A, Balakrishnan S, Barns-Jenkins C, Barr G, Barrell S, Basu S, Beale R, Beesley C, Bhardwaj N, Bibi S, Bineva-Todd G, Biswas D, Blackman M, Bonnet D, Bowker F, Broncel M, Brooks C, Buck M, Buckton A, Budd T, Burrell A, Busby L, Bussi C, Butterworth S, Byrne F, Byrne R, Caidan S, Campbell J, Canton J, Cardoso A, Carter N, Carvalho L, Carzaniga R, Chandler N, Chen Q, Cherepanov P, Churchward L, Clark G, Clayton B, Gigli C, Collins Z, Cottrell S, Crawford M, Cubitt L, Cullup T, Davies H, Davis P, Davison D, D'Avola A, Dearing V, Debaisieux S, Diaz-Romero M, Dibbs A, Diring J, Driscoll P, Earl C, Edwards A, Ekin C, Evangelopoulos D, Faraway R, Fearns A, Ferron A, Fidanis E, Fitz D, Fleming J, Frederico B, Gaiba A, Gait A, Gamblin S, Gandhi S, Gaul L, Golding H, Goldman J, Goldstone R, Dominguez B, Gong H, Grant P, Greco M, Grobler M, Guedan A, Gutierrez M, Hackett F, Hall R, Halldorsson S, Harris S, Hashim S, Healy L, Heaney J, Herbst S, Hewitt G, Higgins T, Hindmarsh S, Hirani R, Hope J, Horton E, Hoskins B, Houlihan C, Howell M, Howitt L, Hoyle J, Htun M, Hubank M, Encabo H, Hughes D, Hughes J, Huseynova A, Hwang M, Instrell R, Jackson D, Jamal-Hanjani M, Jenkins L, Jiang M, Johnson M, Jones L, Kanu N, Kassiotis G, Kiely L, Teixeira A, Kirk S, Kjaer S, Knuepfer E, Komarov N, Kotzampaltiris P, Kousis K, Krylova T, Kucharska A, Labrum R, Lambe C, Lappin M, Lee S, Levett A, Levett L, Levi M, Liu H, Loughlin S, Lu W, MacRae J, Madoo A, Marczak J, Martensson M, Martinez T, Marzook B, Matthews J, Matz J, McCall S, McCoy L, McKay F, McNamara E, Minutti C, Mistry G, Molina-Arcas M, Montaner B, Montgomery K, Moore C, Moore D, Moraiti A, Moreira-Teixeira L, Mukherjee J, Naceur-Lombardelli C, Nastouli E, Nelson A, Nicod J, Nightingale L, Nofal S, Nurse P, Nutan S, Oedekoven C, O'Garra A, O'Leary J, Olsen J, O'Neill O, Suarez P, O'Reilly N, Osborne N, Pabari A, Pajak A, Papayannopoulos V, Patel N, Patel Y, Paun O, Peat N, Castano L, Caballero A, Perez-Lloret J, Perrault M, Perrin A, Poh R, Poirier E, Polke J, Pollitt M, Prieto-Godino L, Proust A, Punatar R, Puvirajasinghe C, Queval C, Ramachandran V, Ramaprasad A, Ratcliffe P, Reed L, Reis e Sousa C, Richardson K, Ridewood S, Roberts R, Rodgers A, Clavijo P, Rosa A, Rossi A, Roustan C, Rowan A, Sahai E, Sait A, Sala K, Sanderson T, Santucci P, Sardar F, Sateriale A, Saunders J, Sawyer C, Schlott A, Schweighoffer E, Segura-Bayona S, Shaw J, Shin G, Dos Santos M, Silvestre M, Singer M, Snell D, Song O, Spyer M, Steel L, Strange A, Sullivan A, Swanton C, Tan M, Tautz-Davis Z, Taylor E, Taylor G, Taylor H, Taylor-Beadling A, Subtil F, Torras B, Toolan-Kerr P, Torelli F, Toteva T, Treeck M, Trojer H, Tsai M, Turner J, Turner M, Ule J, Ulferts R, Vanloo S, Veeriah S, Venkatesan S, Vousden K, Wack A, Walder C, Walker P, Wang Y, Ward S, Wenman C, Wiliams L, Williams M, Wong W, Wright J, Wu M, Wynne L, Xiang Z, Yap M, Zagalak J, Zecchin D, Zillwood R, Matthews R, Severn A, Adam S, Enfield L, McBride A, Gärtner K, Edwards S, Lorencatto F, Michie S, Manley E, Shahmanesh M, Lukha H, Prymas P, McBain H, Shortman R, Wood L, Davies C, Williams B, Ng K, Cornish G, Faulkner N, Riddell A, Hobson P, Agua-Doce A, Bartolovic K, Russell E, Carr L, Sanchez E, Frampton D, Byott M, Paraskevopoulou S, Crayton E, Meyer C, Vora N, Gkouleli T, Stoltenberg A, Ranieri V, Byrne T, Lewer D, Hayward A, Gilson R, Kelly G, Roberts F, Hatipoglu E. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. The Lancet 2020, 396: e6-e7. PMID: 32653078, PMCID: PMC7347344, DOI: 10.1016/s0140-6736(20)31484-7.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply